4.7 Article

Oseltamivir Dosing for Influenza Infection in Premature Neonates

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 202, Issue 4, Pages 563-566

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1086/654930

Keywords

-

Funding

  1. Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases [N01-AI-30025, N01-AI-65306, N01-AI-15113, N01-AI-62554]

Ask authors/readers for more resources

Under the Emergency Use Authorization issued in April 2009, oseltamivir can be used to treat 2009 influenza A (H1N1) virus infection in children aged < 1 year. No data exist on the dosing of oseltamivir in premature babies. A hospital health care worker inadvertently exposed 32 neonatal intensive care unit babies to 2009 influenza A (H1N1); a protocol was expeditiously implemented to collect samples for pharmacokinetics and dosage evaluation. Results suggest 1.0 mg/kg/dose twice daily in premature babies produces oseltamivir carboxylate exposures similar to that in older children receiving 3.0 mg/kg/dose twice daily. These results provide initial guidance on dosing oseltamivir in this vulnerable population.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available